What is Haemonetics's current ratio?

Haemonetics (HAE) reported current ratio of 3× in Q1 2026.

How has Haemonetics's current ratio changed year-over-year?

Haemonetics's current ratio increased by 82.7% year-over-year, from 1.6× to 3×.

What is the long-term trend for Haemonetics's current ratio?

Over 5 years (2021 to 2026), Haemonetics's current ratio has grown at a 1.5% compound annual growth rate (CAGR), from 2.7× to 3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Haemonetics HAE Current ratio

Current ratio at other companies

AbbottABT

1.4×-0.4×

TFX

TeleflexTFX

2.6×+0.3×

Boston ScientificBSX

1.9×+0.4×

MedtronicMDT

2.1×+0.3×

LivaNovaLIVN

1.3×-0.2×

ICU MedicalICUI

2.3×-0.3×

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Where this comes from

Calculated from Haemonetics’s reported figures.

total current assets/total current liabilities=3×

Based on the most recent quarter.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's current ratio?: Haemonetics (HAE) reported current ratio of 3× in Q1 2026.
How has Haemonetics's current ratio changed year-over-year?: Haemonetics's current ratio increased by 82.7% year-over-year, from 1.6× to 3×.
What is the long-term trend for Haemonetics's current ratio?: Over 5 years (2021 to 2026), Haemonetics's current ratio has grown at a 1.5% compound annual growth rate (CAGR), from 2.7× to 3×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.